PlumX Metrics
Embed PlumX Metrics

Results of the safety and tolerability of ivaltinostat plus capecitabine in the phase 1b portion of a phase 1b/2, dose-escalation, randomized, multi-center study in the maintenance (maint) setting in patients with metastatic pancreatic adenocarcinoma (mPDAC).

Journal of Clinical Oncology, ISSN: 0732-183X, Vol: 42, Issue: 3_suppl, Page: 666-666
2024
  • 0
    Citations
  • 4
    Usage
  • 0
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Article Description

2024 ASCO Gastrointestinal Cancers Symposium

Bibliographic Details

Evan Justin Walker; Christos Fountzilas; Erkut Hasan Borazanci; Anthony F. Shields; James Thomas D'Olimpio; J. Randolph Hecht; Shou-Ching Tang; Glenn Michelson; Lorna Liganor; Sangsook Ahn Cho; Andrew H. Ko

American Society of Clinical Oncology (ASCO)

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know